Rizatriptan Benzoate

Spezifikationen

145202-66-0CAS-Nummer

604-465-6EG-Nummer

benzoic acid;N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamineIUPAC-Name

C22H25N5O2Chemische Formel

391.5 g/molMolekulargewicht

Rizatriptan benzoate; 145202-66-0; Maxalt-MLT; RIZAFILM; WR978S7QHH; NSC-758919; L 705126; L 705,126; L-705,126; DTXSID20162937; 1H-Indole-3-ethanamine, N,N-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-, monobenzoate; SYMBRAVO COMPONENT RIZATRIPTAN BENZOATE; 3-(2-(Dimethylamino)ethyl)-5-(1H-1,2,4-triazol-1-ylmethyl)indole monobenzoate; 3-[2-(Dimethylamino)ethyl]-5-(1H-1,2,4-triazol-1-ylmethyl)indole monobenzoate; RefChem:58236; Rizatriptan Benzoate ODT; DTXCID8085428; 1H-Indole-3-ethanamine, N,N-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-, benzoate (1:1); 604-465-6; Maxalt; Rizatriptan (benzoate); MK 462; MK-0462; MFCD00866224; N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine benzoate; Rizatriptan Benzoate (Maxalt); 2-(5-((1H-1,2,4-triazol-1-yl)methyl)-1H-indol-3-yl)-N,N-dimethylethan-1-amine benzoate; benzoic acid;N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine; S1607; Rizatriptanbenzoate; Rizatriptan Benzoate [USAN]; UNII-WR978S7QHH; MK 0462; Rizatriptan benzoate [USAN:USP]; rizatrimptan benzoate; rizatriptane benzoate; rizatriptan, benzoate; Rizatriptan benzoate CRS; N,N-DIMETHYL-5-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-1H-INDOLE-3-ETHANAMINE BENZOATE; SCHEMBL41226; MLS001424197; CHEBI:8875; orb1226245; orb1308386; SCHEMBL3002162; CHEMBL1201032; HY-B0206R; Rizatriptan benzoate (JAN/USP); RHB-103; RIZATRIPTAN BENZOATE [MI]; JPRXYLQNJJVCMZ-UHFFFAOYSA-N; GLXC-05242; HMS2051B16; HMS2093K08; HMS2235M18; HMS3369I15; HMS3393B16; HMS3655K09; HMS3715D08; HMS3884K21; HMS5079M18; Pharmakon1600-01505189; Rizatriptan (benzoate) (Standard); RIZATRIPTAN BENZOATE [JAN]; HY-B0206; INT-0008; RIZATRIPTAN BENZOATE [VANDF]; AC-734; EBC-11267; NSC758919; RIZATRIPTAN BENZOATE [MART.]; RIZATRIPTAN BENZOATE [USP-RS]; RIZATRIPTAN BENZOATE [WHO-DD]; AKOS015855933; Rizatriptan for system suitability CRS; AB07521; CCG-101039; FR27745; KS-1189; NC00289; NSC 758919; RIZATRIPTAN BENZOATE [ORANGE BOOK]; SMR000525252; RIZATRIPTAN BENZOATE [EP MONOGRAPH]; DB-015783; RIZATRIPTAN BENZOATE [USP MONOGRAPH]; Rizatriptan benzoate salt, >=98% (HPLC); R0107; R0181; SW197669-2; D00675; F300988; SR-01000763588; SR-01000763588-3; Q27292788; Rizatriptan benzoate, European Pharmacopoeia (EP) Reference Standard; Rizatriptan benzoate, United States Pharmacopeia (USP) Reference Standard; DIMETHYL-[2-(5-[1,2,4]TRIAZOL-1-YLMETHYL-1H-INDOL-3-YL)-ETHYL]-AMINE BENZOATE; Rizatriptan for system suitability, European Pharmacopoeia (EP) Reference Standard; Benzoic acid--N,N-dimethyl-2-{5-[(1H-1,2,4-triazol-1-yl)methyl]-1H-indol-3-yl}ethan-1-amine (1/1)Synonyme